Sustainable Medicines Manufacturing Innovation: Collaborative R&D

Fund details

Projects must consider both critical enablers: 

• regulations: how to overcome any regulatory barriers to the adoption of your innovation
• measurements, standards and data: approaches to capture data that support the measurement and reporting of sustainability indicators aligned with industry standards

These new manufacturing innovations are expected to support more environmentally sustainable manufacturing processes with significant and measurable improvements in at least one of the following areas:

• productivity
• waste reduction
• emissions reduction
• energy use reduction
• resource efficiency

Funding must be used to invest in innovation to deliver across four key goals:

• drive disruptive and novel technologies or processes in medicines manufacturing to optimise production efficiency, minimise waste and reduce emissions, aligning with global sustainability goals
• facilitate the effective implementation of innovative solutions and promote their adoption across the medicines manufacturing sector, ensuring scalability and widespread utilisation
• enhance the UK’s attractiveness as a prime location for investment in medicines manufacturing, thereby stimulating economic growth and enhancing resilience in the sector
• strengthen the UK's manufacturing innovation ecosystem through collaborative partnerships between academia, industry, and government entities, promoting knowledge exchange and collaborative initiatives to enhance sustainable manufacturing practices

Eligibility 

You must collaborate with other UK registered organisations and you must also involve at least one grant claiming micro, small or medium sized enterprise (SME) in your project.